Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700026794

Trial Profile

Clinical Trials Insight: 700026794

Phase of Trial: Phase I

Latest Information Update: 13 May 2008

At a glance

  • Drugs Tezampanel (Primary)
  • Indications Anxiety disorders; Cancer pain; Epilepsy; Migraine; Neuromuscular disorders; Pain; Postoperative pain
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors TorreyPines Therapeutics Inc
  • Most Recent Events

    • 13 May 2008 Status changed to completed, according to a ToreyPines media release.
    • 05 Feb 2008 Results reported in a TorreyPines media release.
    • 06 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top